ResearcherUniversity College LondonActive in the last 2 years
Alexey A. Zaikin
Matched on ORCID iD 0000-0001-7540-1130; OpenAlex author ID A5029926969. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- Graph Neural Network Modelling of Pre-Diagnostic Serum Proteomics for Pancreatic Cancer Detection. Co-author DOI 10.3390/diagnostics16203283↗
- Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early pancreatic cancer detection. Co-author DOI 10.1371/journal.pcbi.1012408↗
- Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients. First author DOI 10.1038/s41416-019-0694-0↗
- Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early disease detection. Co-author DOI 10.1158/1078-0432.ccr-14-0365↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Oleg B. Blyuss · 4 shared papers, 2015–2026 · strength 0.66
- Paper Graph Neural Network Modelling of Pre-Diagnostic Serum Proteomics for Pancreatic Cancer Detection. DOI 10.3390/diagnostics16203283↗
- Paper Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early p… DOI 10.1371/journal.pcbi.1012408↗
- Paper Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients. DOI 10.1038/s41416-019-0694-0↗
- Stephen P. Pereira · 2 shared papers, 2015–2024 · strength 0.23
- Paper Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early p… DOI 10.1371/journal.pcbi.1012408↗
- Paper Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early… DOI 10.1158/1078-0432.ccr-14-0365↗
- Eithne Costello · 2 shared papers, 2015–2024 · strength 0.23
- Paper Identification of a serum proteomic biomarker panel using diagnosis specific ensemble learning and symptoms for early p… DOI 10.1371/journal.pcbi.1012408↗
- Paper Serum CA19-9 is significantly upregulated up to 2 years before diagnosis with pancreatic cancer: implications for early… DOI 10.1158/1078-0432.ccr-14-0365↗
- Pilar Acedo · 1 shared paper, 2024 · strength 0.19
- Alexander Ney · 1 shared paper, 2024 · strength 0.19
- Giuseppe Fusai · 1 shared paper, 2024 · strength 0.19
- Tatjana Crnogorac‐Jurcevic · 1 shared paper, 2020 · strength 0.12
- Claire Jenkinson · 1 shared paper, 2015 · strength 0.04
- Ross C. Smith · 1 shared paper, 2015 · strength 0.04
- Darragh Patrick O'Brien · 1 shared paper, 2015 · strength 0.04
- John F. Timms · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.